Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CD97
REST API REST API
Homo sapiens
CD97 is differentially expressed in 292 experiments: 135 organism parts: lung, uterus, ... (133 more);, 204 disease states: normal, control, ... (202 more);, 116 cell types 360 cell lines 34 compound treatments and 64 other conditions.
Synonyms TM7LN1
Orthologs CD97 (3 of 3) (Danio rerio)   Cd97 (Mus musculus)   A6QNW8_BOVIN (Bos taurus)   CD97 (1 of 3) (Danio rerio)   CD97 (2 of 3) (Danio rerio)   Cd97 (Rattus norvegicus)   cd97 (Xenopus laevis)   Q2Q423_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term plasma membrane, protein binding, G-protein coupled receptor activity, cellular component movement, extracellular space, neuropeptide signaling pathway, membrane, G-protein coupled receptor protein signaling pathway, extracellular region, cell-cell signaling, signal transducer activity, cell adhesion, cell surface receptor linked signaling pathway, integral to plasma membrane, receptor activity, immune response, integral to membrane, calcium ion binding, inflammatory response, transmembrane signaling receptor activity
InterPro Term GPS_dom, GPCR_2-like, EGF, EGF_3, GPCR_2_secretin-like, EGF-like, GPCR_2_EMR1_rcpt, GPCR_2_CD97, EGF-like_Ca-bd
UniProt Accession P48960, F5H3G2
Search EB-eye ENSG00000123146
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-6573, E-MEXP-433, E-GEOD-2549, ... (33 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (39 experiments)

Factor Value U/D Experiments
BT474
3
E-MEXP-440, E-MTAB-62, E-MTAB-37
MCF-7
3
E-GEOD-19639, E-GEOD-20081, E-GEOD-5823
SW480
3
E-MEXP-1014, E-GEOD-18005, E-MTAB-37
LNCaP
2
E-GEOD-14990, E-GEOD-14464
MOLT4
2
E-MTAB-62, E-MTAB-37
T84
2
E-GEOD-1474, E-MTAB-37
354 more value(s).


Cell type

studied in E-GEOD-492, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-TABM-34, ... (54 experiments)

Factor Value U/D Experiments
induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
CD14+ monocyte
2
E-AFMX-5, E-TABM-145
CD56+ NK cells
2
E-AFMX-5, E-TABM-145
embryonic stem cell
2
E-MEXP-930, E-GEOD-2248
endothelial cell
2
E-GEOD-3920, E-GEOD-19240
whole blood
2
E-GEOD-3026, E-MTAB-25
110 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-TABM-15, E-GEOD-16363, ... (60 experiments)

Factor Value U/D Experiments
control
1
4
E-GEOD-21912, E-GEOD-16363, E-GEOD-20602, E-GEOD-8121, E-GEOD-20295 ... (5 experiments)
multiple myeloma
3
E-GEOD-6691, E-MTAB-62, E-GEOD-2113
colon carcinoma
3
E-GEOD-3726, E-MTAB-37, E-MTAB-62
glioblastoma
3
E-GEOD-4290, E-GEOD-4412, E-MTAB-37
AIDS-KS, HIV+, nodular (late) stage
2
E-MTAB-62, E-MEXP-66
retinoblastoma
2
E-MTAB-37, E-GEOD-96
198 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-6907, E-GEOD-5741, E-GEOD-15205, E-GEOD-3720, ... (23 experiments)

Factor Value U/D Experiments
none
3
4
E-GEOD-412, E-GEOD-5824, E-GEOD-2803, E-GEOD-5099, E-MEXP-1601, ... (7 experiments)
poly(I:C)
1
E-MEXP-1230
saline
1
E-GEOD-3026
unknown
1
E-GEOD-7307
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
LDL
1
E-GEOD-5741
28 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-MTAB-37, E-GEOD-6710, E-GEOD-994, E-MEXP-1251, E-GEOD-21374, ... (11 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-4667, ... (7 experiments)

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-22544, E-GEOD-3325, E-GEOD-22148, ... (8 experiments)

Environmental stress
studied in E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-7578, E-GEOD-20847, E-GEOD-6431, ... (6 experiments)

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, E-GEOD-21750, ... (10 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-12773, E-TABM-127, E-GEOD-20540, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-1926, E-GEOD-16363, E-GEOD-430, ... (31 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980 ... (5 experiments)

Injury
studied in E-GEOD-19743

Irradiate
studied in E-GEOD-1977

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-26495, E-GEOD-19703, E-GEOD-22152, E-GEOD-22309, E-GEOD-21750, ... (8 experiments)

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

Replicate
studied in E-GEOD-10896

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-MEXP-70, E-GEOD-17400, E-GEOD-18995 ... (5 experiments)

Sex
studied in E-GEOD-1643, E-GEOD-7307

Stimulation
studied in E-GEOD-11886, E-GEOD-23984

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-GEOD-1926, E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-19815, E-GEOD-15799

Tumor grading
studied in E-GEOD-4290, E-GEOD-4922

Processing time: 0.278 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM